Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Hansoh Pharmaceutical Group Company Limited    3692   KYG549581067

HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

(3692)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
01/15/2021 01/18/2021 01/19/2021 01/20/2021 01/21/2021 Date
43.85 43.6 44.65 44.9 45.05 Last
4511972 1973000 3656000 4056092 2859496 Volume
-0.23% -0.57% +2.41% +0.56% +0.33% Change
Financials
Sales 2020 9 655 M 1 492 M 1 492 M
Net income 2020 2 993 M 463 M 463 M
Net cash position 2020 7 428 M 1 148 M 1 148 M
P/E ratio 2020 75,2x
Yield 2020 0,26%
Sales 2021 11 911 M 1 841 M 1 841 M
Net income 2021 3 623 M 560 M 560 M
Net cash position 2021 8 982 M 1 388 M 1 388 M
P/E ratio 2021 61,5x
Yield 2021 0,31%
Capitalization 222 B 34 399 M 34 358 M
EV / Sales 2020 22,3x
EV / Sales 2021 17,9x
Nbr of Employees 10 159
Free-Float 18,1%
More Financials
Company
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED is a China-based investment holding company principally involved in the the research and development, production and sale of pharmaceutical products. The Company’s main products include Oulanning, Ameining, Pulaile, Zefei, Xinwei, Xinmei, Zetan, Mailingda, Hengjie, Hengsen, Fulaidi and Ruibote, among others. The Company’s products are mainly used for central nervous... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Notations Surperformance© of Hansoh Pharmaceutical Group Company Limited
Trading Rating : Investor Rating :
More Ratings
All news about HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
01/12China stocks mixed on profit-taking; consumer, healthcare down
RE
01/07HANSOH PHARMACEUTICAL : Pharma to Issue $600 Million of Zero Coupon Convertible ..
MT
01/05Hong Kong stocks close higher on telecoms support
RE
2020Hansoh Pharmaceutical's Schizophrenia Drug Wins Registration Approval in Chin..
MT
2020HANSOH PHARMACEUTICAL : First-half Net Profit Fell 5.7%
DJ
2020HANSOH PHARMACEUTICAL : Voluntary announcement - drug registration approval of "..
PU
2020HANSOH PHARMACEUTICAL : Inside information - license agreement with eqrx
PU
More news
News in other languages on HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
2020HANSOH PHARMACEUTICAL : Studie - Vermögen der Milliardäre erreichen Rekord trotz..
More news
Chart HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Duration : Period :
Hansoh Pharmaceutical Group Company Limited Technical Analysis Chart | 3692 | KYG549581067 | MarketScreener
Technical analysis trends HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 36,65 CNY
Last Close Price 37,56 CNY
Spread / Highest target 19,9%
Spread / Average Target -2,42%
Spread / Lowest Target -32,3%
EPS Revisions
Managers and Directors
NameTitle
Hui Juan Zhong Chairman & Chief Executive Officer
Ai Feng Lyu Executive Director
Yu An Sun Executive Director
Cui Fang Ma Non-Executive Director
Guo Qiang Lin Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED19.81%34 399
JOHNSON & JOHNSON2.76%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.90%202 881